Brain Aneurysm Treatment Market Size Worth $ 6,222.47 Mn by 2027

The brain aneurysm treatment market was valued at US$ 2,184.15 million in 2019 and is expected to grow at a CAGR of 14.1% from 2020to 2027 to reach US$ 6,222.47 million by 2027.

The global brain aneurysm treatment market, based on the type, is segmented into medications and surgery. The medication segment held the largest share of the market in 2019. However, surgery segment is estimated to register the highest CAGR in the market during the forecast period. The growth of surgery segment is prominently attributed to effectiveness of surgeries for the treatment of brain aneurysm. The end user segment is segmented into hospitals and clinics.

Get sample PDF Copy at: https://www.theinsightpartners.com/sample/TIPRE00004588/?utm_source=OpenPR&utm_medium=10144

Leading companies operating in the brain aneurysm treatment market are Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Mizuho Medical Co, Ltd, Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., KANEKA CORPORATION, adeor medical AG, and Evasc Medical Systems Corp among others.

The brain aneurysm treatment market for is expected to grow, owing to factors such as increasing prevalence of brain aneurysm and associated risk factors and rise in research and development activities are likely to have a positive impact on the growth of the market in coming years.

Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market is driven by factors such as increasing prevalence of brain aneurysm and risk factors associated with it. Additionally, growing research and development activities in the field of brain and neurological disorders is also anticipated to drive the brain aneurysm market growth during the forecast period.

Other companies in this space are also focusing on collaborative efforts to introduce new technologies and medical devices for the treatment of brain aneurysm. For instance, in December 2018, Medtronic received FDA approval for its Pipeline Flex, a permanent mesh cylinder (stent) for the treatment of brain aneurysm. Additionally, in January 2020, MicroVention, Inc. got FDA approval for its FRED (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms. An increasing number of such research and development activities are accelerating the growth of the market.

The report segments global brain aneurysm treatment market as follows:

Global Brain aneurysm treatment Market – By Type

Surgery
Medication
Global Brain aneurysm treatment Market – By Condition

Unruptured Aneurysm
Ruptured Aneurysm
Global Brain aneurysm treatment Market – By End User

Hospitals
Clinics

Buy This Report at: https://www.theinsightpartners.com/buy/TIPRE00004588/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876